Abstract A total of 242 HIV-1-infected children were followed up at the Complexe Pédiatrique
of Bangui, Central African Republic, including 165 receiving antiretroviral treatment in first …

A large cohort of 220 HIV-1-infected children (median [range] age: 12 [4–17] years) was
cared and followed up in the Central African Republic, including 198 in 1st-line and 22 in …

We describe changes in HIV-1 viral load, CD4+ T cell percentage, and incidence of drug
resistance and factors associated with drug resistance for 134 children receiving …

Objectives To evaluate the virological response and to describe the resistance profiles in the
case of failure after 6 months of first-line highly active antiretroviral therapy (HAART) in HIV-1 …

We sought to determine the pattern of resistance-associated mutations (RAMs) among HIV-1-
infected children failing first-line antiretroviral therapy (ART) and ascertain their response to …

The rates of virological failure (VF) and HIV-1 drug resistance were evaluated in a cross-
sectional study in HIV-1-infected children living in Dakar, and taking antiretroviral treatment …

Pediatric human immunodeficiency virus (HIV) care in resource-limited settings remains a
major challenge to achieving global HIV treatment and virologic suppression targets, in part …

Objective: To estimate the frequency of human immunodeficiency virus type 1 (HIV-1)
displaying genotypic drug resistance in highly active antiretroviral therapy (HAART)-treated …

Barriers to sustainable virologic suppression (VS) of HIV-infected adolescents and young
adults include drug resistance mutations (DRMs) and limited treatment options, which may …

Introduction In recent years, children born to HIV-infected mothers have been receiving
antiretroviral treatment (ART) with limited or no virologic monitoring, which increases the …